Article

When worlds converge: How Most-Favored-Nation policy and International Reference Pricing reshape global market access interdependencies

  • Erika Wissinger

    Erika Wissinger, PhD

  • headshot

    David Ringger, PhD

  • Casper pardekooper

    Casper Paardekooper, MSc

  • Diane Smith headshot

    Diane Smith, PhD

  • Rafael de Alencar headshot

    Rafael de Alencar, MSc

This article was originally published on ISPOR

Global drug pricing decisions do not happen in isolation

This article explores how most favored nation policies and international reference pricing are reshaping global market access by linking pricing, reimbursement, and launch decisions across markets. It highlights why manufacturers need a more coordinated strategy to anticipate downstream effects on pricing, access, and commercialization. 

Click below to read the full article today.

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
abstract

Related resources

Article

The price patients pay: A peek into the financial burden for breast cancer patients diagnosed with mental health comorbidities
Learn more

Article

RWE Insights: The contribution of German claims data to scientific evidence generation
Learn more

Article

When prices travel: How Most Favored Nation and international reference pricing are reshaping global market access
Learn more